La chaîne d'options affiche les données clés des options sur actions de GE Vernova à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour GE Vernova..

GE Vernova (NYSE:GEV) Stock, Chaîne d'Options

GE Vernova

GE Vernov

GE Vernova is a global leader in the electric power industry, with products and services that generate, transfer, convert, and store electricity. The company has three business segments: power, wind, and electrification. Power includes gas, nuclear, hydroelectric, and steam technologies, providing dispatchable power. The wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. Electrification includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, and storage of electricity from the point of generation to point of consumption.

GE Vernova Inc

GENERAL ENTERPRISE VENTUR by GENERAL ENTERPRISE VENTURES INC.

General Enterprise Ventures Inc

Gevo Inc

GE VERNOVA ORD

TD Cowen analyst Bryan Bergin maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Buy and raises the price target from $200 to $230.

News

Price Target

Analyst Ratings

TD Cowen Maintains Buy on Fiserv, Raises Price Target to $230

TD Cowen analyst Dan Brennan maintains Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) with a Buy and raises the price target from $310 to $315.

TD Cowen Maintains Buy on Danaher, Raises Price Target to $315

JP Morgan analyst Jay Kwon downgrades LG Display Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPL#NYSE">LPL</a>) from Overweight to Neutral.

Downgrades

JP Morgan Downgrades LG Display Co to Neutral

Jefferies analyst Brian Tanquilut maintains Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) with a Hold and lowers the price target from $19 to $9.

Jefferies Maintains Hold on Walgreens Boots Alliance, Lowers Price Target to $9

TD Cowen analyst Charles Rhyee maintains Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) with a Buy and lowers the price target from $413 to $372.

MEDP

TD Cowen Maintains Buy on Medpace Hldgs, Lowers Price Target to $372

Financial giants have made a conspicuous bullish move on ServiceNow. Our analysis of options history for ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) revealed 38 unusual trades.
Delving into the details, we found 39% of traders were bullish, while 28% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $394,047, and 30 were calls, valued at $2,480,134.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $520.0 and $1000.0 for ServiceNow, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of ServiceNow stands at 150.58, with a total volume reaching 1,748.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in ServiceNow, situated within the strike price corridor from $520.0 to $1000.0, throughout the last 30 days.
<h3>ServiceNow Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729707342_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$193.0</td>
<td>$184.1</td>
<td>$187.25</td>
<td>$860.00</td>
<td>$936.2K</td>
<td style="text-align: right;">25</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$33.8</td>
<td>$30.6</td>
<td>$32.0</td>
<td>$1000.00</td>
<td>$153.6K</td>
<td style="text-align: right;">289</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$37.8</td>
<td>$37.0</td>
<td>$37.0</td>
<td>$950.00</td>
<td>$148.0K</td>
<td style="text-align: right;">127</td>
<td style="text-align: right;">40</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/25/24</td>
<td>$22.7</td>
<td>$21.0</td>
<td>$21.4</td>
<td>$890.00</td>
<td>$102.7K</td>
<td style="text-align: right;">78</td>
<td style="text-align: right;">68</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/25/24</td>
<td>$27.0</td>
<td>$25.5</td>
<td>$27.0</td>
<td>$910.00</td>
<td>$91.8K</td>
<td style="text-align: right;">79</td>
<td style="text-align: right;">43</td>
</tr>
</tbody>
</table>

<h3>About ServiceNow</h3>
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
In light of the recent options history for ServiceNow, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is ServiceNow Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 738,362, with NOW's price down by -1.48%, positioned at $904.41.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>Professional Analyst Ratings for ServiceNow</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $987.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley has revised its rating downward to Equal-Weight, adjusting the price target to $960. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on ServiceNow, which currently sits at a price target of $1025. 
&#x2A; An analyst from Evercore ISI Group has decided to maintain their Outperform rating on ServiceNow, which currently sits at a price target of $950. 
&#x2A; Maintaining their stance, an analyst from Mizuho continues to hold a Outperform rating for ServiceNow, targeting a price of $980. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on ServiceNow, which currently sits at a price target of $1020. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ServiceNow options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Spotlight on ServiceNow: Analyzing the Surge in Options Activity

On Tuesday, DBV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) announced progress in its regulatory efforts for the Viaskin Peanut patch, aimed at treating peanut allergies in <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41467627/dbv-announces-positive-regulatory-updates-for-the-viaskin-peanut-patch-in-the-united-states-and-eu" rel="noreferrer noopener">toddlers and children</a>.
The company has aligned with the FDA under the Accelerated Approval Program for toddlers aged 1–3.
DBV has agreed to the FDA&#8217;s guidance on key study components required for approval, including the COMFORT Toddlers safety study, which must be completed before the US marketing application submission, and a confirmatory study to demonstrate the patch&#8217;s effectiveness.
DBV plans to begin enrolling subjects in the COMFORT Toddlers study in the second quarter of 2025, with <a target="_blank" href="https://www.benzinga.com/general/biotech/23/08/33487292/dbv-technologies-advances-peanut-allergy-program-with-fda-support-on-pediatric-studies" rel="noreferrer noopener">around 300–350 toddlers</a>.
DBV has also made headway on the Viaskin Peanut patch for older children. In September 2024, the company completed patient screening for the Phase 3 VITESSE trial, enrolling 654 children aged 4–7 years. Topline data are expected in the fourth quarter of 2025.
Discussions between DBV and the FDA have also addressed the patch&#8217;s adhesion issues. The company proposed a labeling solution that links adhesion data to the patch&#8217;s efficacy and safety.
DBV also received scientific advice from the European Medicines Agency for a broader age range of 1–7 years in Europe.
In Europe, DBV has received scientific advice confirming that the EPITOPE study in 1–3-year-olds and positive results from the VITESSE study could support the European marketing application for the 1–7-year-old age group.
The company is planning a new safety study for toddlers with the modified patch to meet European requirements.
Despite its clinical progress, DBV&#8217;s financial situation raises concerns. The company reported cash and cash equivalents of $46.4 million as of September 30, 2024, and anticipates that this will fund operations only through the first quarter of 2025.
With ongoing operating losses, DBV has expressed uncertainty about its ability to continue operations without securing additional funding. The company is actively seeking new capital to support its research and potential product launch.
Price Action: DBVT stock is up 44.3% at $1.02 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41486950/boeing-q3-earnings-revenue-and-profit-decline-cultural-challenges-ceo-ortberg-vows-transformation" target="_blank" rel="noreferrer noopener">Boeing Q3 Earnings: Revenue And Profit Decline, Cultural Challenges, CEO Ortberg Vows Transformation</a>.</li>
</ul>

Health Care

Movers

General

DBVT

Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway

Investors with a lot of money to spend have taken a bearish stance on Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 14 uncommon options trades for Mastercard.
This isn't normal.
The overall sentiment of these big-money traders is split between 35% bullish and 50%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $161,337, and 10 are calls, for a total amount of $541,947.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $380.0 and $540.0 for Mastercard, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Mastercard's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Mastercard's whale activity within a strike price range from $380.0 to $540.0 in the last 30 days. 
<h3>Mastercard 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729707336_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$66.7</td>
<td>$64.6</td>
<td>$66.0</td>
<td>$450.00</td>
<td>$151.8K</td>
<td style="text-align: right;">107</td>
<td style="text-align: right;">23</td>
</tr>
<tr>
<td>MA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$28.5</td>
<td>$27.75</td>
<td>$27.75</td>
<td>$540.00</td>
<td>$135.9K</td>
<td style="text-align: right;">492</td>
<td style="text-align: right;">103</td>
</tr>
<tr>
<td>MA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$10.9</td>
<td>$10.9</td>
<td>$10.9</td>
<td>$530.00</td>
<td>$52.2K</td>
<td style="text-align: right;">85</td>
<td style="text-align: right;">123</td>
</tr>
<tr>
<td>MA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$21.2</td>
<td>$20.75</td>
<td>$21.05</td>
<td>$525.00</td>
<td>$50.7K</td>
<td style="text-align: right;">78</td>
<td style="text-align: right;">24</td>
</tr>
<tr>
<td>MA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$21.2</td>
<td>$20.75</td>
<td>$21.05</td>
<td>$525.00</td>
<td>$48.4K</td>
<td style="text-align: right;">78</td>
<td style="text-align: right;">47</td>
</tr>
</tbody>
</table>

<h3>About Mastercard</h3>
Mastercard is the second-largest payment processor in the world, having processed close to over $9 trillion in volume during 2023. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.
Following our analysis of the options activities associated with Mastercard, we pivot to a closer look at the company's own performance.
<h3>Mastercard's Current Market Status</h3>
<ul>
<li>With a volume of 693,191, the price of MA is up 0.08% at $513.43. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 8 days.</li>
</ul>
<h3>Professional Analyst Ratings for Mastercard</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $581.3333333333334.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Mastercard, maintaining a target price of $593. 
&#x2A; An analyst from Barclays has decided to maintain their Overweight rating on Mastercard, which currently sits at a price target of $576. 
&#x2A; An analyst from Baird has decided to maintain their Outperform rating on Mastercard, which currently sits at a price target of $575. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Mastercard options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Market Whales and Their Recent Bets on Mastercard Options

Jefferies analyst Randal Konik maintains SharkNinja (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) with a Buy and raises the price target from $115 to $150.

Jefferies Maintains Buy on SharkNinja, Raises Price Target to $150

Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer.
Looking at options history for Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 22% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $215,253 and 4, calls, for a total amount of $110,938.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $23.0 to $32.0 for Pfizer over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Pfizer's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale activity within a strike price range from $23.0 to $32.0 in the last 30 days. 
<h3>Pfizer Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729707330_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$0.85</td>
<td>$0.83</td>
<td>$0.83</td>
<td>$28.00</td>
<td>$76.2K</td>
<td>23.4K</td>
<td>1.1K</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/25/24</td>
<td>$0.35</td>
<td>$0.28</td>
<td>$0.28</td>
<td>$29.00</td>
<td>$35.4K</td>
<td>6.8K</td>
<td>550</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/08/24</td>
<td>$3.5</td>
<td>$3.4</td>
<td>$3.45</td>
<td>$32.00</td>
<td>$34.5K</td>
<td>339</td>
<td>320</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$3.5</td>
<td>$3.45</td>
<td>$3.45</td>
<td>$32.00</td>
<td>$34.5K</td>
<td>339</td>
<td>220</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/08/24</td>
<td>$3.5</td>
<td>$3.45</td>
<td>$3.45</td>
<td>$32.00</td>
<td>$34.5K</td>
<td>339</td>
<td>120</td>
</tr>
</tbody>
</table>

<h3>About Pfizer</h3>
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Having examined the options trading patterns of Pfizer, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Pfizer Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 13,273,870, with PFE's price down by -0.12%, positioned at $28.8.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 6 days.</li>
</ul>
<h3>Professional Analyst Ratings for Pfizer</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $40.666666666666664.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Bernstein downgraded its action to Market Perform with a price target of $32. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $45. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $45.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pfizer, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

A Closer Look at Pfizer's Options Market Dynamics

TD Cowen analyst Moshe Orenbuch maintains Enova International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENVA#NYSE">ENVA</a>) with a Hold and raises the price target from $85 to $96.

ENVA

TD Cowen Maintains Hold on Enova International, Raises Price Target to $96

Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>) reported better-than-expected second-quarter FY25 results on Tuesday.
Revenue rose 6% (both reported and constant currencies) to $1.116 billion, marginally exceeding the consensus of $1.11 billion. Adjusted EPS of $1.20 beat the consensus of $0.99.
The company raised its FY25 sales outlook to $4.39 billion -$4.47 billion, up 2% – 4% (from the previously expected $4.34 billion – $4.43 billion) versus the consensus of $4.512 billion. Logitech now sees an adjusted operating income of $720 million – $750 million (versus $700 million – $730 million prior view).
Hanneke Faber, chief executive officer, said, "Growth was broad-based, across regions, categories, and both our consumer and business customers. We launched a terrific set of innovations in the quarter and we are ready for the holidays."
Logitech shares fell 4.4% to trade at $80.26 on Wednesday.
These analysts made changes to their price targets on Logitech following earnings announcement.
<ul>
<li>Barclays analyst Tim Long maintained Logitech International with an Overweight and lowered the price target from $105 to $103.</li>
<li>JP Morgan analyst Samik Chatterjee maintained the stock with a Neutral and lowered the price target from $98 to $93.</li>
<li>Wedbush analyst Alicia Reese reiterated Logitech International with a Neutral and maintained a price target of $88.</li>
</ul>
Considering buying LOGI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="529" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/23141018/image-220-1024x529.png" alt="" class="wp-image-610437" style="width:718px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/23141018/image-220-1024x529.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/23141018/image-220-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/23141018/image-220-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/23141018/image-220.png 1211w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41488681/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Tech Stocks Delivering High-Dividend Yields</a></li>
</ul>

Earnings

Trading Ideas

LOGI

Logitech International Analysts Slash Their Forecasts Following Q2 Results

TD Cowen analyst Cai von Rumohr maintains Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) with a Buy and raises the price target from $560 to $610.

TD Cowen Maintains Buy on Lockheed Martin, Raises Price Target to $610

<a href="https://www.benzinga.com/topic/jim-cramer">Jim Cramer is</a> once again ringing the bell for Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) fans. On CNBC's &#8220;Mad Money,&#8221; the fiery host recommended holding on to the AI stock, saying, &#8220;There is no level that the buyers won't take this stock higher.&#8221;
But while Cramer is urging investors to ride the momentum, let's dive into what the charts tell us ahead of Palantir's third-quarter earnings.
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102324&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="628" height="455" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/23122444/Screenshot-2024-10-23-at-9.54.12-PM.png" alt="" class="wp-image-610185" style="width:920px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/23122444/Screenshot-2024-10-23-at-9.54.12-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/23122444/Screenshot-2024-10-23-at-9.54.12-PM-300x217.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent102324&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
<h1 class="wp-block-heading">Bullish Wave Continues — But Beware the Overbought Zone</h1>
Palantir stock has been on an absolute tear this year, up a staggering 158% year-to-date. From a technical standpoint, the stock is basking in bullish glory, sitting comfortably above its five-, 20- and 50-day moving averages. The current price of $42.70 spells bullish across key indicators such as the eight-day SMA ($42.63) and the 20-day SMA ($40.80).
With a Moving Average Convergence/Divergence (MACD) of 2.02, the momentum favors the bulls. The stock's Relative Strength Index (RSI) at 67.56 is inching toward overbought territory, suggesting some caution is warranted.
Read Also: <a href="https://www.benzinga.com/top-stories/24/10/41486894/jim-cramer-says-hold-on-to-palantir-let-them-walk-it-up-warns-that-travere-therapeutics-is-losing-a">Jim Cramer Says &#8216;Hold On&#8217; To Palantir, &#8216;Let Them Walk It Up&#8217;; Warns That Travere Therapeutics Is Losing A &#8216;Ton Of Money&#8217;</a>
While Cramer may be encouraging investors to hold on and enjoy the ride, technicals hint that Palantir could be due for a breather.
<h1 class="wp-block-heading">Q3 Earnings on the Horizon: Will AI Hype Keep the Stock Climbing?</h1>
With the third quarter earnings less than two weeks away (on Nov. 4), Palantir's AI-powered momentum could continue driving investor excitement.
But, as the RSI suggests, this rocket ride may face turbulence soon.
For now, Palantir stock has bullish chart signals, but investors should keep one eye on the stock&#8217;s overbought status as it heads into earnings.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/esg/24/10/41488713/tesla-stock-faces-selling-pressure-ahead-of-q3-earnings-4-takeaways-from-the-chart">Tesla Stock Faces Selling Pressure Ahead Of Q3 Earnings: 4 Takeaways From The Chart</a></li>
</ul>
Photo: Shutterstock

Technicals

Tech

PLTR

Jim Cramer's Bullish On Palantir, But Is The Stock's Winning Streak Too Hot?

DA Davidson analyst Gil Luria maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Buy and raises the price target from $285 to $315.

MANH

DA Davidson Maintains Buy on Manhattan Associates, Raises Price Target to $315

TD Cowen analyst Joseph Giordano maintains Pentair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNR#NYSE">PNR</a>) with a Buy and raises the price target from $95 to $110.

TD Cowen Maintains Buy on Pentair, Raises Price Target to $110

DA Davidson analyst Kevin Reevey maintains Wintrust Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>) with a Buy and raises the price target from $125 to $130.

WTFC

DA Davidson Maintains Buy on Wintrust Finl, Raises Price Target to $130

Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest <a href="https://www.benzinga.com/earnings">batch of corporate earnings.</a>
Both equities and commodities took a hit on Wednesday, while the U.S. dollar gained strength, attracting investor flows as traders moved to safer cash positions.
The U.S. dollar index, as tracked by the the&nbsp;Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), rose 0.5%, reaching levels last seen in late July. 
At midday in New York, the S&amp;P 500 was down 0.7%, attempting to hold support around the 5,800-point level. The Dow Jones also dropped 0.7%, and tech stocks, along with small caps, fared worse, sliding by 0.9%.
On the data front, mortgage applications declined for the fourth straight week, reflecting continued pressure <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41488744/mortgage-applications-fall-for-fourth-straight-week-as-high-rates-squeeze-homebuy">from elevated borrowing costs.</a>
Existing home sales fell by 1% in September to a seasonally adjusted annualized rate of 3.84 million, the lowest level since October 2010. This follows an upwardly revised 3.88 million in August and missed forecasts of 3.9 million.
Despite weak housing data, real estate stocks showed surprising resilience. The Vanguard Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNQ#NYSE">VNQ</a>) and the SPDR Homebuilders ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHB#NYSE">XHB</a>) moved higher after two straight sessions of losses.
Gold prices, as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), fell more than 1%, pulling mining stocks down with it. Silver plummeted over 3%, retreating from 12-year highs reached on Tuesday.
Oil prices slipped by 1%, while Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) tumbled 2%. 
<h1 class="wp-block-heading">Wednesday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,815.02</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,625.59</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,213.10</td>
<td>-0.9%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,196.24</td>
<td>-0.9%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated 12:00 p.m. ET </figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent102224&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.6% to $579.72.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.7% lower to $426.41.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 1% to $491.16.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.7% $219.80.</li>
<li>The Real Estate Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) outperformed, up 0.6%. The Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) lagged, down 1%.</li>
</ul>
<h1 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h1>
<ul>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) fell 2.4% after reporting a worse-than-expected losses<a href="https://www.benzinga.com/news/earnings/24/10/41486950/boeing-q3-earnings-revenue-and-profit-decline-cultural-challenges-ceo-ortberg-vows-transformation"> last quarter</a>.</li>
</ul>
Other stocks reacting to earnings included:
<ul>
<li>Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), up 3.5%.</li>
<li>Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), up 3.9%.</li>
<li>Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), down over 7%.</li>
<li>Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>), up over 6%.</li>
<li>Manhattan Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), down over 7%.</li>
<li>East West Bancorp. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>), up over 7%.</li>
<li>Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), down over 13%.</li>
<li>Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), down 2.2%. </li>
<li>Thermo Fisher Scientific Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), down 2.9%.</li>
<li>NextEra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>), down 0.1%. </li>
<li>AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>), up 3.8%. </li>
<li>Boston Scientific Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>), down 3.7%. </li>
<li>CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), down 0.9%. </li>
<li>GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), down 1.6%. </li>
<li>Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>), down 2.6%. </li>
<li>Vertiv Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>), down 2.8%. </li>
<li>Old Dominion Freight Line Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>), down 4.8%. </li>
</ul>
Large-cap companies reporting earnings after the close include Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), T-Mobile US Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>), International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>), ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), Lam Research Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), Newmont Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), United Rentals Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>), Las Vegas Sands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>), Raymond James Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>). 
Read Now:
<ul>
<li><a href="https://www.benzinga.com/markets/bonds/24/10/41455678/gold-on-track-for-best-year-since-1979-veteran-investor-says-sell-bonds-buy-gold">Gold On Track For Best Year Since 1979: Veteran Investor Says &#8216;Sell Bonds, Buy Gold&#8217;</a></li>
</ul>

Equities

Large Cap

Macro Economic Events

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ENPH

EWBC

LRCX

ODFL

TMUS

TSLA

PowerShares DB US Dollar Index Bullish Fund

XLRE

Select Sector SPDR-Consumer Discretionary

Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?

With Tesla Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/quote/TSLA/earnings">earnings report fast approaching</a>, stock traders are gearing up for a wild ride. From concerns over margins to Tesla's AI ambitions, plenty is at stake, and traders are split on what to expect. 
In an exclusive interview with Benzinga, Ed Egilinsky, managing director at Direxion, offered insight into what metrics traders are watching and how they're positioning themselves for the next big move.
<h2 class="wp-block-heading">Exclusive Insight: Gross Margins, Pricing Power Under The Microscope</h2>
"There will be a focus on several metrics with auto gross margins being top of mind," said Egilinsky. As Tesla faces pressure from domestic and foreign competitors, traders eagerly await additional data.
"Traders will be focusing on any signs that pricing power has returned or stabilized, along with any update on the timing of lower-priced models," Egilinsky said, highlighting the tension around Tesla's pricing strategy.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/24/10/41449625/tesla-or-google-who-will-steer-the-future-of-self-driving">Tesla Or Google? Who Will Steer The Future Of Self-Driving?</a>
<h2 class="wp-block-heading">Competition, Margin Pressure Weigh On Tesla Stock Sentiment</h2>
Egilinsky emphasized rising global automotive rivalry as another key issue, noting, "Increasing competition, both with U.S. automakers, most recently with GM&#8217;s earnings announcement, as well as domestic carmakers in China taking market share away from Tesla might hamper its growth outlook."
While the stock has rebounded from earlier lows, margin pressure is leading some bears to position for further declines. "Some feel that the stock's current valuations are stretched and are positioning themselves for the October stock slide to continue post earnings," Egilinsky said.
<h2 class="wp-block-heading">AI Ambitions Keep Tesla Bulls Holding On</h2>
Despite these challenges, bullish sentiment remains. "We have seen significant inflows into our Direxion Daily TSLA 2X Bull ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLL#NASDAQ">TSLL</a>) over the last week," Egilinsky noted. Tesla&#8217;s AI ambitions, including robotaxis and autonomous driving, are inspiring long-term optimism.
However, Egilinsky cautioned, "The likelihood that this will be impactful on a broader scale within the tech and auto sectors over the short term is less likely."
For traders, the upcoming earnings will be critical to see if Tesla can balance near-term pressures with its longer-term AI bets.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/esg/24/10/41488713/tesla-stock-faces-selling-pressure-ahead-of-q3-earnings-4-takeaways-from-the-chart">Tesla Stock Faces Selling Pressure Ahead Of Q3 Earnings: 4 Takeaways From The Chart</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534;WATCH LIVE: Tesla Q3 2024 Earnings Call &#x7C; $TSLA" width="500" height="281" src="https://www.youtube.com/embed/hO2duXOICWA?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Image created using artificial intelligence via Midjourney.

Previews

Exclusives

Interview

TSLL

EXCLUSIVE: Tesla Earnings To Test 'Pricing Power,' AI Ambitions Against Rising Competition

TD Cowen analyst Jason Seidl maintains Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) with a Hold and raises the price target from $253 to $259.

TD Cowen Maintains Hold on Norfolk Southern, Raises Price Target to $259

Andrew Obin, an analyst from Bank of America Securities, maintained the Buy rating on GE Vernova Inc. (GEV – Research Report). The associated price...

GE Vernova Inc.: Strategic Advancements and Strong Market Position in Small Modular Reactors Drive Buy Rating

Mizuho Securities analyst Maheep Mandloi has maintained their bullish stance on GEV stock, giving a Buy rating today. Maheep Mandloi has given his ...

GE Vernova Inc.: Strong Growth Potential Driven by Power Segment and Strategic Financial Management

GE Aerospace's stock declines on slim sales growth

GE Vernova GAAP EPS of -$0.35 misses by $0.61, revenue of $8.9B beats by $140M

Unusual total active option classes on open include: Banco Bilbao (BBVA), Canadian Pacific (CP), McDonald's (MCD), Analog Devices (ADI), Starbucks ...

Unusually active option classes on open October 23rd

J.P. Morgan analyst Mark Strouse has maintained their bullish stance on GEV stock, giving a Buy rating yesterday. Mark Strouse has given his Buy ra...

GE Vernova Inc. Rated 'Buy' by Analyst Mark Strouse Amid Strong Q3 Performance and Positive Outlook

GE Vernova (GEV) and Vineyard Wind provided an update on the implementation of their Incident and Response and Action Plan announced in August. The...

GE Vernova intends to remove some blades from Vineyard Wind farm

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: McDonald's (MCD) shares are continuing...

McDonald's down after outbreak, Starbucks slides after warning: Morning Buzz

Evercore ISI raised the firm's price target on GE Vernova (GEV) to $323 from $300 and keeps an Outperform rating on the shares. The firm updated it...

GE Vernova price target raised to $323 from $300 at Evercore ISI

GE Vernova Inc. (GEV) Q3 2024 Earnings Call Transcript

ACHR

BBVA

CSTM

EBAY

GEHC

SAVE

SBUX

SNAP

TVGN

ULCC

Press Releases

GE Vernova to Announce First Quarter 2024 Financial Results on April 25

GE Vernova Recommends Shareholders Reject "Mini-Tender" Offer by TRC Capital Investment Corporation

The New York Stock Exchange Leads Industry in Global IPO Proceeds for the First Half of 2024

GEV Investors Have Opportunity to Join GE Vernova Inc. Securities Fraud Investigation with the Schall Law Firm

Legal

GE Vernova Inc. (GEV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

FLUT

IBTA

KFRC

RBRK

RDDT

SOLV

VRTS

Bloom Energy Corporation Class A Common Stock

Bloom Energy

Babcock & Wilcox Enterprises, Inc. Common Stock

Babcock & Wilcox

Broadwind

Clean Energy Technologies, Inc. - Common Stock

Clean Energy Technologies

Nano Nuclear Energy

NET Power

Energy Vault Holdings

Ocean Power Technologies, Inc. Common Stock

Ocean Power Techs

Polar Power

Pioneer Power Solutions, Inc. - Common Stock

Pioneer Power Solutions

NuScale Power Corporation Class A Common Stock

Comments

GE Vernova

GE Vernova (GEV) Options

GE Vernova (NYSE:GEV) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL